Aker BioMarine’s PL+ technology platform will help enhance the bioavailability of dietary supplement ingredients, taking the nutra industry to new heights
There is no question that in order to be relevant in today’s market, supplement brands need to stay ahead of the curve when it comes to innovation. For ingredient companies like Aker BioMarine, reliant on decades worth of research, experience and R&D, there are many new growth opportunities on the horizon.
In fact, the company is excited to announce the debut of its new disruptive technology platform, PL+ by Aker BioMarine, aimed at utilizing the true potential of phospholipids (PL’s), to help bring new products to market.
The phospholipids found in krill oil are the perfect delivery format to help bring specific ingredients together to unlock the true potential of various nutrient benefits. Phospholipids have excellent biocompatibility and are both water and fat soluble and multiple publications have demonstrated the benefits of using phospholipids as a self-emulsifying delivery platform for supplements with low bioavailability and absorption into the body.
By combining PL’s with other ingredients that have lower bioavailability and absorption rates into the body we can boost and enhance the uptake of of these ingredients up to 25 times, bringing new cost effective and better-quality supplements to market.
“We believe PL+ is a real industry gamechanger for the nutraceuticals industry,” said Matts Johansen, CEO of Aker BioMarine. “Since our debut into the supplements industry over 15 years ago, we knew we had a special ingredient with krill due to its phospholipid advantage, and for years we have investigated the true potential of PL’s and are excited to bring this new technology platform to life.”